Abstract:BACKGROUND:An alarming increment in pathogenic resistance to existing anti-microbial agents is a serious problem and the treatment of these bacterial infections is becoming increasingly challenging. Therefore, there is an urgent need to develop novel antimicrobial agents.OBJECTIVE:As a part of our ongoing studies toward the development of novel antibacterial agents, the synthesis and antibacterial activity of a series of (Z)-5-((3-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one derivatives will be discussed in this study.METHOD:(Z)-5-((3-phenyl-1H-pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one derivatives were designed, synthesized and evaluated for antibacterial activity. The structures were confirmed by IR, 1H NMR, 13C NMR and mass spectrometry. All of the synthesized compounds were evaluated in vitro using a 96-well microtiter plate and a serial dilution method to obtain their minimum inhibitory concentration (MIC) values against a variety of different strains, including multidrug-resistant clinical isolates.RESULTS:The antibacterial test in-vitro showed that most compounds in series 7 and 9 exhibited significant inhibitory activities against anaerobic bacteria (Streptococcus mutans) strains with a MIC value of 1 µg/mL. Compounds 7c and 9c showed the most potent activity against MRSA (3167 and 3506) with a minimum inhibitory concentration (MIC) value of 1 µg/mL, which is equivalent to moxifloxacin and greater than gatifloxacin, oxacillin and norfloxacin. Additionally, compound 9c showed potent antibacterial activity against Bacillus subtilis (aerobic bacteria) with a MIC value of 2 µg/mL.CONCLUSION:The work suggests that these type of rhodanine compounds had a better potent activity against MRSA compared with other perviously reported rhodanine derivatives, which might provide a valuable information for the development of new antibacterial agents against multidrug-resistant clinical isolates MRSA.

Thiazolidione Derivatives As Novel Antibiofilm Agents: Design, Synthesis, Biological Evaluation, and Structure-Activity Relationships

Design, Synthesis, and Antibiofilm Activity of 2-Arylimino-3-aryl-thiazolidine-4-ones

Anti-bacterial and Anti-biofilm Evaluation of Thiazolopyrimidinone Derivatives Targeting the Histidine Kinase YycG Protein of Staphylococcus Epidermidis.

Synthesis and Biological Evaluation of 3-(Pyridine-3-yl)-2-oxazolidinone Derivatives As Antibacterial Agents.

Antibacterial And Anti-Biofilm Activities Of Thiazolidione Derivatives Against Clinical Staphylococcus Strains

Novel Fluorinated Pyrrolomycins As Potent Anti-Staphylococcal Biofilm Agents: Design, Synthesis, Pharmacokinetics and Antibacterial Activities.

Synthesis, Structural Characterization, and Biological Activities of 1,3,4‐ thiadiazole Derivatives Containing sulfonylpiperazine structures

Synthesis of novel 4-thiazolidione derivatives as antibacterial agents against drug-resistant Staphylococcus epidermidis

Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1h-pyrazol-4- Yl)methylene)-2-thioxothiazolidin-4-one Derivatives

Fused Imidazo[1,2‐d][1,2,4]Thiadiazolo[1,2,3]Triazoles: One‐Pot Synthesis, Anti‐Bacterial, Anti‐Biofilm and TLR4 Inhibitory Activities

Synthesis and Biological Evaluation of Halogenated 2-Arylimino-3-arythiazolidine- 4-Ones Containing Benzoic Acid Fragments As Antibacterial Agents

Design, synthesis and biological evaluation of thiazolyl-halogenated pyrroles or pyrazoles as novel antibacterial and antibiofilm agents

Synthesis and Biological Activities of Thio-Triazole Derivatives As Novel Potential Antibacterial and Antifungal Agents

Development of novel indolin-2-one derivative incorporating thiazole moiety as DHFR and quorum sensing inhibitors: Synthesis, antimicrobial, and antibiofilm activities with molecular modelling study

Novel [1,3,4]Thiadiazole[3,2-a]pyrimidin-5-ones as Promising Biofilm Dispersal Agents against Relevant Gram-Positive and Gram-Negative Pathogens

Optimization and Antibacterial Evaluation of Novel 3-(5-Fluoropyridine-3-yl)-2-oxazolidinone Derivatives Containing a Pyrimidine Substituted Piperazine

Synthesis and Biological Evaluation of a Novel Series of 1,5-Benzothiazepine Derivatives As Potential Antimicrobial Agents

Design, one-pot synthesis, in silico ADMET prediction and molecular docking of novel triazolyl thiadiazine and thiazole derivatives with evaluation of antimicrobial, antioxidant and antibiofilm inhibition activity

Expanded library of novel 2,3-pyrrolidinedione analogues exhibit anti-biofilm activity

Design, Synthesis and Antimicrobial Activities of Novel 1,3,5-Thiadiazine-2-thione Derivatives Containing a 1,3,4-Thiadiazole Group

Synthesis of New Imidazolo‐Benzenesulfonamide Linked 1,2,3‐Triazoles as Potent Antibacterial and Antibiofilm Agents